96898-75-8

Basic information

• Product Name: 4-CHLORO-3-NITROBENZAMIDE OXIME
• Synonyms: Benzenecarboximidamide, 4-chloro-N-hydroxy-3-nitro-
• CAS NO: 96898-75-8
• Molecular Formula: C₇H₆ClN₃O₃
• Molecular Weight: 215.59
• Mol File: 96898-75-8.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-CHLORO-3-NITROBENZAMIDE OXIME(CAS DataBase Reference)
• NIST Chemistry Reference: 4-CHLORO-3-NITROBENZAMIDE OXIME(96898-75-8)
• EPA Substance Registry System: 4-CHLORO-3-NITROBENZAMIDE OXIME(96898-75-8)

Safety Data

• Hazardous Substances Data: 96898-75-8(Hazardous Substances Data)

Usage

General Description

4-CHLORO-3-NITROBENZAMIDE OXIME is a chemical compound with the molecular formula C7H5ClN2O3. It is a yellow crystalline solid and is primarily used as an intermediate in the production of pharmaceuticals and other organic compounds. The compound is also used as a reagent in organic synthesis and as a building block for the creation of more complex chemicals. It is important to handle 4-CHLORO-3-NITROBENZAMIDE OXIME with care, as it is known to be harmful if swallowed or inhaled, and can cause irritation to the skin and eyes. Proper safety precautions and handling procedures should be followed when working with this chemical.

Upstream product

• 939-80-0 4-chloro-3-nitrobenzonitrile 

Downstream Products

• 187399-90-2 5-(Chloromethyl)-3-(4'-chloro-3'-nitrophenyl)-1,2,4-oxadiazole 
• 96898-95-2 3-(4-chloro-3-nitrophenyl)-1,2,4-oxadiazole 
• 862298-34-8 4-chloro-N'-[(cyclopropylcarbonyl)oxy]-3-nitrobenzenecarboximideamide 
• 862298-33-7 N'-acetyloxy-4-chloro-3-nitrobenzenecarboximideamide 

Relevant articles and documents

((11-OXO-10,11-DIHYDRODIBENZO [B, F] [1, 4] OXAZEPIN-1-YL)OXY) ACETIC ACID DERIVATIVES AND RELATED COMPOUNDS AS CARDIOVASCULAR PREPARATIONS USED TO TREAT ARTERIOLOSCLEROSIS

The invention relates to dibenzoxazepines and to a method for the production thereof, use thereof in the treatment and/or prophylaxis of illnesses, in addition to the use thereof in the production of medicaments for treating and/or for the prophylaxis of diseases, in particular cardiovascular illnesses, e.g. arteriolosclerosis, and cancers: Said dibenzoxazepines are represented by formula (I), wherein R2 represents C1-C6-alkyl, alkyl can be substituted by 1 or 2 substituents, said substituents are selected independently from each other from the group consisting of halogen, hydroxy, oxo, C1-C6-alkoxy, hydroxycarbonyl, C1-C6-alkoxycarbonyl, aminocarbonyl and C1-C6-alkylaminocarbonyl, R3 represents O-CH2CO2H or -O-(CH2)2CO2H, R5 represents 5- 10-membered heteroaryl, -SO2-R6 or -NR7(C=O)R8, whereby heteroaryl can be substituted by 1, 2 or 3 substituents, said substituents being selected independently from each other from the group consisting of halogen, trifluoromethyl, trifluoromethoxy, cyano, nitro, amino, C1-C6 alkylamino, hydroxy, C1-C6-alkyl, C1-C6-aIkoxy, hydroxycarbonyl, C1-C6-alkoxycarbonyl, amino-carbonyl, C1-C6-alkylaminocarbonyl, C6-C10-aryl and C3-C8-aycloalkyl. The other substituents are defined in the claims.